Is the Epworth Sleepiness Scale Measuring What You Think?

The Epworth Sleepiness Scale is an 8-question survey that asks you to rate how likely you are to doze off in various situations: sitting and reading, watching TV, sitting in a meeting, lying down in the afternoon. You rate each from 0 (no chance of dozing) to 3 (high chance), for a maximum score of 24.

A score above 10 is generally considered "excessive sleepiness." Below 10 is "normal." The ESS has been the standard tool for assessing daytime sleepiness in sleep medicine since 1991, and it's used in virtually every sleep clinic in the world.

There's just one problem: it conflates two fundamentally different things.

Objective sleepiness is the tendency to fall asleep. It can be measured with tools like the Multiple Sleep Latency Test (MSLT), which objectively measures how fast you fall asleep in controlled conditions. It's a specific physiological state.

Fatigue is the subjective experience of exhaustion, lack of energy, or feeling drained. You can be profoundly fatigued without being sleepy. Many people with chronic fatigue syndrome, fibromyalgia, or UARS describe being utterly exhausted but unable to nap, even when given the opportunity.

The ESS asks you to rate your likelihood of dozing. If your primary symptom is fatigue rather than sleepiness, you'll score low on the ESS even though you're profoundly impaired. And your doctor will tell you you're fine.

Drs. Avram Gold and Riccardo Stoohs recently published a study in Sleep Medicine that directly addresses this issue. Their finding: the Epworth Sleepiness Scale measures an uninterpretable mix of objective sleepiness and fatigue.

This matters because objective sleepiness and fatigue may have different underlying mechanisms. Objective sleepiness in OSA correlates with inflammation markers (IL-6) and decreased cortisol. Fatigue may be driven by chronic HPA axis activation from the stress response to flow limitation, which is a different pathway entirely.

This is where the ESS problem and the flow limitation research converge. Dr. Gold's earlier work showed that UARS patients (the mildest end of sleep-disordered breathing) actually have a higher prevalence of fatigue, insomnia, IBS, and headaches than patients with more severe OSA.

If these patients present to a sleep clinic, they'll fill out the ESS. Many will score below 10 because their primary complaint is fatigue, not sleepiness. The clinic may conclude they don't have a significant sleep problem. And even if they get a sleep study, their AHI will be low.

The result: the patients who may benefit most from recognizing and treating flow limitation are the ones most likely to be screened out by the standard tools.

• Know the difference. If your main complaint is fatigue or exhaustion rather than the urge to fall asleep, a low ESS score does not rule out a sleep-disordered breathing problem. Make sure your clinician knows the distinction.
• Request objective testing. The MSLT measures objective sleepiness directly. If your ESS is low but you feel impaired, objective testing can reveal whether there's a measurable sleep drive issue vs. a fatigue issue.
• Look at your breathing data directly. If you're on PAP therapy, your SD card contains breath-by-breath flow data that can reveal flow limitation your ESS score will never capture. Tools like AirwayLab can quantify this.
• Advocate for yourself. Bring the research to your clinician. The Gold & Stoohs paper provides a peer-reviewed basis for questioning ESS-only screening in patients whose symptoms are primarily fatigue.